Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

MDMA

Expanding Horizons $20.677M Market Capitalization Optimi Health Corp. (OPTI.C) announced today that it has entered into a supply agreement with SABI Mind. According to the terms of the agreement,…
Numinus Wellness (NUMI.T) got the Health Canada nod to study ayahuasca and San Pedro at its research facility, Numinus Bioscience today. The license expansion works to boost NUMI’s profile…
$144.185M Market Capitalization Numinus Wellness Inc. (NUMI.T) announced today that it has completed key steps in preparation for enrollment at the Company’s clinics participating in a “multi-site open-label extension…
Mydecine Innovations Group (MYCO.NEO) inked a letter of intent (LOI) with Alberta-based inter-disciplinary mental health clinic operator, The Newly Institute, to collaborate on getting psychedelic assisted therapy to patients….
The world’s first psychedelic ETF, PSYK, is an industry bellwether which indicates the psychedelics space continues to take a drubbing since the ETF launched in January.  The fund closed…
Numinus Wellness (NUMI.V) announced today that it has closed its acquisition of the Neurology Centre of Toronto (NCT). “NCT by Numinus represents an important paradigm shift in neurologic care…By…
Awakn Life Sciences (AWKN.NE) announced it has received ethical approval to conduct the first-ever study of the effects of ketamine on gambling addiction. Awakn has begun to recruit patients…
MindMed (MNMD.Q) will participate and assist in the financing of the Digital Medicine Society’s (DiMe) Digital Health Measurement Collaborative Community (DATAcc) in the development of best practices, and the…
Mydecine Innovations (MYCO.NE) announced they are filing a new patent for their MDMA-like compounds. In the press release Mydecine writes that “this expansive patent would allow Mydecine to scale…
Numinus Wellness (NUMI.V) announced that Health Canada has cleared their MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). The study is being…